feedburner

Enter your email address:

Delivered by FeedBurner

USFDA pulls up Mylan for manufacturing violations at Andhra plant

In a warning letter issued to the company's CEO Heather Bresch, the US
Food and Drug Administration (USFDA) said inspectors during May 27 to
June 5, this year found significant deviations from standard
manufacturing practices at the company's Unit 8 in G Chodavaram
village in Vizianagaram.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/usfda-pulls-up-mylan-for-manufacturing-violations-at-andhra-plant/articleshow/72107827.cms



0 comments:

Post a Comment